Found: 6
Select item for more details and to access through your institution.
Lower risk of hospitalization for heart failure, kidney disease and death with sodium‐glucose co‐transporter‐2 inhibitors compared with dipeptidyl peptidase‐4 inhibitors in type 2 diabetes regardless of prior cardiovascular or kidney disease: A retrospective cohort study in UK primary care
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2207, doi. 10.1111/dom.14437
- By:
- Publication type:
- Article
Lower cardiorenal risk with sodium‐glucose cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 75, doi. 10.1111/dom.14189
- By:
- Publication type:
- Article
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1607, doi. 10.1111/dom.14074
- By:
- Publication type:
- Article
Variation in surgical treatment advice for women with stress urinary incontinence: a study using clinical case vignettes.
- Published in:
- International Urogynecology Journal, 2020, v. 31, n. 6, p. 1153, doi. 10.1007/s00192-020-04295-4
- By:
- Publication type:
- Article
Correction to: Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals.
- Published in:
- 2022
- By:
- Publication type:
- corrected article
Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals.
- Published in:
- 2022
- By:
- Publication type:
- journal article